2022
33933 Relationship between skin involvement and disease burden in patients with mild to moderate plaque psoriasis: Real-world findings From CorEvitas’ Psoriasis Registry
Ogdie A, Strober B, Lebwohl M. 33933 Relationship between skin involvement and disease burden in patients with mild to moderate plaque psoriasis: Real-world findings From CorEvitas’ Psoriasis Registry. Journal Of The American Academy Of Dermatology 2022, 87: ab103. DOI: 10.1016/j.jaad.2022.06.444.Peer-Reviewed Original Research
2013
SAT0267 Safety of Ustekinumab from the Placebo-Controlled Periods of Psoriatic Arthritis and Psoriasis Clinical Developmental Programs
McInnes I, Papp K, Puig L, Reich K, Ritchlin C, Strober B, Rahman P, Kavanaugh A, Mendelsohn A, Song M, Chan D, Shen Y, Li S, Gottlieb A. SAT0267 Safety of Ustekinumab from the Placebo-Controlled Periods of Psoriatic Arthritis and Psoriasis Clinical Developmental Programs. Annals Of The Rheumatic Diseases 2013, 72: a673. DOI: 10.1136/annrheumdis-2013-eular.1992.Peer-Reviewed Original ResearchGrant/research supportPsA populationOverall safety ratePsO/PsASafety event rateRates of AEsHigh rateActive PsA.Pt-yrRelevant comorbiditiesMedian durationPASI scorePsoriatic arthritisSkin involvementConcurrent therapyBSA involvementMedical historyFamily historySafety rateOverall AEEvent ratesPSAConfidence intervalsSimilar proportionsResearch support